"Antithyroid Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.
| Descriptor ID |
D013956
|
| MeSH Number(s) |
D06.347.100 D27.505.696.399.450.100
|
| Concept/Terms |
Antithyroid Agents- Antithyroid Agents
- Agents, Antithyroid
- Thyroid Antagonists
- Antagonists, Thyroid
- Antithyroid Drugs
- Drugs, Antithyroid
Antithyroid Effect- Antithyroid Effect
- Effect, Antithyroid
- Antithyroid Effects
- Effects, Antithyroid
|
Below are MeSH descriptors whose meaning is more general than "Antithyroid Agents".
Below are MeSH descriptors whose meaning is more specific than "Antithyroid Agents".
This graph shows the total number of publications written about "Antithyroid Agents" by people in this website by year, and whether "Antithyroid Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2017 | 1 | 3 | 4 |
| 2018 | 3 | 1 | 4 |
| 2019 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antithyroid Agents" by people in Profiles.
-
Antithyroid arthritis syndrome in a case of post-COVID-19 subacute thyroiditis. Diabetes Metab Syndr. 2021 May-Jun; 15(3):683-686.
-
Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations. BMJ Case Rep. 2021 Jan 08; 14(1).
-
Management of Graves Thyroidal and Extrathyroidal Disease: An Update. J Clin Endocrinol Metab. 2020 12 01; 105(12).
-
SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19. J Endocrinol Invest. 2020 Oct; 43(10):1527-1528.
-
Hypothyroidism and Its Association With Sleep Apnea Among Adults in the United States: NHANES 2007-2008. J Clin Endocrinol Metab. 2019 11 01; 104(11):4990-4997.
-
Comparison of Five TSH-Receptor Antibody Assays in Graves' disease: results from an observational pilot study. BMC Endocr Disord. 2019 Apr 25; 19(1):38.
-
A Grave Case of Vomiting. Am J Med. 2018 11; 131(11):e459-e460.
-
Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management. J Endocrinol Invest. 2018 Dec; 41(12):1425-1432.
-
Post-partum and non-post-partum relapsing Graves' hyperthyroidism display different response to anti-thyroid drugs. Eur J Endocrinol. 2018 Jun; 178(6):589-594.
-
A patient-specific treatment model for Graves' hyperthyroidism. Theor Biol Med Model. 2018 01 09; 15(1):1.